Leveraging the advances in HIV for COVID-19
James H McMahon, Jennifer F Hoy, Adeeba Kamarulzaman, Linda-Gail Bekker, Chris Beyrer, Sharon R Lewin
LANCET | ELSEVIER SCIENCE INC | Published : 2020
JHM reports that his institution had received funding to conduct clinical trials from Gilead Sciences, ViiV Healthcare, Merck Sharp & Dohme Australia. JFH reports personal fees paid to her institution from Gilead Sciences, ViiV Healthcare, and Merck Sharp & Dohme Australia. SRL reports grants from the National Health and Medical Research Council of Australia, the National Institutes of Health; American Foundation for AIDS Research, Gilead Sciences, Merck, ViiV, Leidos, the Wellcome Trust, Australian Centre for HIV and Hepatitis Virology Research, Melbourne HIV Cure Consortium, Department of Health and Human Services, and the Medical Research Future Fund. AK, L-GB, and CB declare no competing interests.